---
category: news
title: "Neprilysin Inhibition Has No Impact on Cognitive Function in Heart Failure Patients"
excerpt: "Heart failure patients are more likely to develop dementia Sacubitril/valsartan, a standard treatment for those with heart failure and previously suspected to exacerbate cognitive impairment ..."
publishedDateTime: 2022-09-01T13:42:00Z
originalUrl: "https://www.medindia.net/news/healthwatch/neprilysin-inhibition-has-no-impact-on-cognitive-function-in-heart-failure-patients-208470-1.htm"
webUrl: "https://www.medindia.net/news/healthwatch/neprilysin-inhibition-has-no-impact-on-cognitive-function-in-heart-failure-patients-208470-1.htm"
ampWebUrl: "https://www.medindia.net/amp/news/healthwatch/neprilysin-inhibition-has-no-impact-on-cognitive-function-in-heart-failure-patients-208470-1.htm"
cdnAmpWebUrl: "https://www-medindia-net.cdn.ampproject.org/c/s/www.medindia.net/amp/news/healthwatch/neprilysin-inhibition-has-no-impact-on-cognitive-function-in-heart-failure-patients-208470-1.htm"
type: article

provider:
  name: Medindia
  domain: medindia.net

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://www.medindia.net/images/common/news/950_400/sacubitril-valsartan-does-not-exacerbate.jpg"
    width: 735
    height: 400
    isCached: true

secured: "R+mbDtUoAbiDy5E6yrjpFQQol7gR58jfJERmLOfVQjbP/0+VPsJXpBiCmL8GpAPBM+ii/LhpGs7TsWJ+DzfpNKSaKTyTSe7pSuK7hjX86/tJeOUf3SmG+gq4O4a0dvDAcqaiPn4LWAhKRILurGiGm3OfPb8C7bWq2hyQfQxYVuLnvrPrbv6j6egsD5AViiasis+ZI/XYqdKLrDYMYRJiwQKbxP0qKn/ojCsbIlj+kfY21lSOzg95hx4bq/YE4S8gJr4FJGfjf6DljAbeBipVrdYsZ88rG8rbh7K+f1MOArLfBmnNr+QXQJ/1k7Alrez0tyNqbxISAYtRVD3+u9Fu5rgWKk5sTSZjdvBUBxk3GTs=;3g30nJI6eyIx6tVSY2nqjw=="
---

